LOS ANGELES - Five days after a jury returned a $6.5 million verdict, a California state court judge on May 1 granted defendant Takeda Pharmaceuticals America Inc. a nonsuit in the first Actos bladder cancer trial after finding that the specific causation testimony by the plaintiff's sole expert was unreliable (Actos Product Liability Cases, No. JCCP4696, Jack Cooper, et al. v. Takeda Pharmaceuticals America, Inc., et al., No. CGC-12-518535, Calif. Super., Los Angeles Co.; See 5/2/13, Page 4...(read more)![]()
↧